An effective and stability‐indicating method development and optimization utilizing the Box–Behnken design for the simultaneous determination of acetaminophen, caffeine, and aspirin in tablet formulation
Biomedical Chromatography · 2023-04 · 37 (4)
DOI: 10.1002/bmc.5585 ↗At a glance
Journal article in Biomedical Chromatography, published online on 2023-02-11. Written by Parvateesam Yenda and 5 co-authors. Institution: Department of Chemistry, School of Science, GITAM Deemed to Be University, Hyderabad, India. Major MEDLINE topics: Acetaminophen, Caffeine. Cited 22 times so far (Crossref); 45 references. Funded by: GITAM University.
Abstract (original language)
Analytical techniques must be sensitive, specific, and accurate to assess the active pharmaceutical ingredients in pharmaceutical dosage forms. The quality‐by‐design (QbD) application has proven to be a practical method for magnifying HPLC operations. This article discusses the successfully developed QbD‐based stability‐indicative LC method for evaluating acetaminophen, caffeine, and aspirin (ASP) in tablet dosage form. To achieve the necessary chromatographic separation, Milli‐Q water, methanol, and glacial acetic acid were employed in the following ratios: 63:35:2 (v/v/v) for mobile phase A and 18:80:2 (v/v/v) for mobile phase B. The flow rate, column temperature, and detecting wavelength were 1.0 ml/min, 40°C, and 275 nm, respectively, and an InertSustain C18 analytical column (150 × 4.6 mm, 3 μm) was used. Linearity was between 10.0 and 150.0 μg/ml for ASP and acetaminophen and between 2.6 and 39.0 μg/ml for caffeine. The accuracy findings were more than 97%, and the correlation coefficient for all three components was found to be greater than 0.999. The validated HPLC method yielded reliable and accurate results. ASP was shown to be vulnerable to both acid and alkaline hydrolysis in the forced degradation study. The described method is capable of separating the degradants produced during stress testing and is regarded as stability indicating. The proposed method can be used for a wider range of other formulations with an appropriate diluent selection and sample preparation procedure optimization.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry, School of Science, GITAM Deemed to Be University, Hyderabad, India.
- Department of Quality Control, Aurex Laboratories LLC, East Windsor, New Jersey, USA.
- Analytical Research and Development, Slayback Pharma India LLP, Manjeera Trinity Corporate, JNTU, Hyderabad, India.
- Analytical Research and Development, Catalent Pharma Solutions, 1100 Enterprise Dr, Winchester, Kentucky, 40391, USA.
ORCID profiles: Naresh Kumar Katari, Santhosh Kumar Ettaboina, Siva Krishna Muchakayala, Rambabu Gundla
Funding
- GITAM University
Cite
APA
Yenda, P., Katari, N. K., Ettaboina, S. K., Satheesh, B., Muchakayala, S. K., & Gundla, R. (2023). An effective and stability‐indicating method development and optimization utilizing the Box–Behnken design for the simultaneous determination of acetaminophen, caffeine, and aspirin in tablet formulation. Biomedical Chromatography, 37(4). https://doi.org/10.1002/bmc.5585
Vancouver
Yenda P, Katari NK, Ettaboina SK, Satheesh B, Muchakayala SK, Gundla R. An effective and stability‐indicating method development and optimization utilizing the Box–Behnken design for the simultaneous determination of acetaminophen, caffeine, and aspirin in tablet formulation. Biomedical Chromatography. 2023;37(4). doi:10.1002/bmc.5585
BibTeX
@article{Yenda2023,
author = {Yenda, Parvateesam and Katari, Naresh Kumar and Ettaboina, Santhosh Kumar and Satheesh, Balasubramanian and Muchakayala, Siva Krishna and Gundla, Rambabu},
title = {An effective and stability‐indicating method development and optimization utilizing the Box–Behnken design for the simultaneous determination of acetaminophen, caffeine, and aspirin in tablet formulation},
journal = {Biomedical Chromatography},
year = {2023},
volume = {37},
number = {4},
doi = {10.1002/bmc.5585}
}
EUVIMED